Neogen CORP

Neogen Corporation announced its fiscal year 2026 fourth quarter and full fiscal year results, highlighting strong core growth in Food Safety and providing financial guidance for fiscal year 2027.

Neogen Corporation is hosting investor tours of its Petrifilm facility and has completed operational qualifications for certain Petrifilm SKUs.

Neogen Corporation announced third quarter fiscal year 2026 financial results, reporting a revenue decrease of 4.4% to $211.2 million, while also revealing the divestiture of its Genomics business for $160 million.

Neogen Corporation announced that its Chief Legal and Administrative Officer, Amy Rocklin, will leave the company effective March 31, 2026.

Neogen Corporation reported second-quarter fiscal 2026 results, showing a 2.8% revenue decrease year-over-year but a 2.9% core revenue increase, and raised its full-year 2026 revenue and Adjusted EBITDA guidance.

Neogen Corporation announced the appointment of Bryan Riggsbee, a seasoned financial leader from bioMérieux and Myriad Genetics, as its new Senior Vice President and Chief Financial Officer, effective November 3, 2025.

Neogen Corporation reported a revenue decrease for the third quarter of fiscal year 2026, driven by divestitures, while also announcing plans to sell its genomics business.

Neogen Corporation reported a net income of $20.4 million for the first six months of fiscal year 2026, primarily driven by a divestiture gain, despite a 3% revenue decline and ongoing operational inefficiencies.

Neogen Corporation reported a net income of $36.3 million for Q1 FY2026, primarily driven by a $76.4 million gain from the sale of its Cleaners & Disinfectants business, despite a 4% revenue decline and an operating loss.

Neogen Corporation's Q3 2025 results reveal a net loss driven by a significant goodwill impairment charge and ongoing integration challenges, despite some revenue growth in specific product lines.

Neogen Corporation's Q2 2025 results reveal a substantial net loss primarily driven by a $461.4 million goodwill impairment charge in its Food Safety segment.

Neogen Corporation's first quarter of fiscal year 2025 saw a decrease in revenue and a net loss, impacted by foreign exchange headwinds and lower sales volumes.

Neogen Corporation's Form 10-K for the fiscal year ended May 31, 2026, details a revenue decrease driven by divestitures, ongoing integration challenges, and a net loss, while also outlining strategic initiatives for future growth.

Neogen Corporation announced a significant net loss of over $1 billion for fiscal year 2025, primarily driven by substantial goodwill impairment charges and a decrease in total revenues across its Food Safety and Animal Safety segments.

Neogen Corporation's 10-K filing reveals a year of growth and integration following the 3M Food Safety merger, alongside ongoing efforts to enhance internal controls and navigate global economic challenges.

John Patrick Moylan, Chief Accounting Officer of NEOGEN CORP, reported the vesting of 2,553 Restricted Stock Units on June 3, 2026.

Amy Rocklin, former Chief Legal Officer of Neogen Corp, reported transactions involving the accelerated vesting and sale of company stock.

John Patrick Moylan, Chief Accounting Officer of NEOGEN CORP, reported a transaction involving the sale of 4,558 shares of common stock on May 4, 2026.

Neogen Corp's Chief Legal Officer, Jennifer Stacey, acquired 39,349 shares of common stock on May 1, 2026, at a price of $9.53 per share.

NEOGEN CEO Mikheal Nassif's son acquired a total of 49 common shares in two separate transactions in early 2026, with the CEO explicitly disclaiming beneficial ownership.

NEOGEN Senior Vice President Tamara A. Ranalli reported the acquisition of common stock and derivative securities, including options and restricted stock units, with future vesting schedules.

Neogen Corporation has filed definitive additional materials related to its proxy statement, indicating further disclosures for shareholders.

Neogen Corporation announced its 2025 Annual Meeting, detailing executive and board changes, a significant shift in executive compensation strategy following shareholder feedback, and reporting financial performance below expectations due to market and integration challenges.

Neogen Corporation will hold its 2024 Annual Meeting of Shareholders virtually on October 24, 2024, to vote on the election of directors, executive compensation, and the ratification of the company's independent auditor.

Neuberger Berman Group LLC and its affiliates have reported beneficial ownership of 7.6% of Neogen Corp's common stock as of June 30, 2026.

Clarkston Capital Partners, LLC, along with affiliated entities and individuals, has filed an amended Schedule 13G detailing their beneficial ownership of Neogen Corporation's common stock.

Vanguard Capital Management has reported beneficial ownership of 11,164,628 shares, representing 5.13% of Neogen Corp's common stock, as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 5.93% of Neogen Corp's common stock as of March 31, 2026.

The Vanguard Group, Inc. has reported a 0% beneficial ownership in Neogen Corp common stock following an internal realignment effective January 12, 2026.

ING Groep N.V. and its subsidiary, ING Capital Markets LLC, have filed an amended Schedule 13G disclosing a beneficial ownership of 3.99% in NEOGEN CORP common stock.